FWL INVESTMENT MANAGEMENT, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1829231 Dallas, TX

Position in RXRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$201

+$33 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#335

of 340 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FWL INVESTMENT MANAGEMENT, LLC holds $34,514 across 4 Biotechnology names. RXRX ranks #4 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	333	$18,671
2	VRTX	Vertex Pharmaceuticals Inc / Ma	30	$14,901
3	AKTS	Aktis Oncology, Inc.	23	$741
4	RXRX	Recursion Pharmaceuticals, Inc. This page	55	$201

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$201	55	0.0%	Shares	Sole	2026-08-14
2026-03-31	$168	55	0.0%	Shares	Sole	2026-05-15
2025-12-31	$224	55	-93.1%	Shares	Sole	2026-02-17
2025-09-30	$3,904	800	+3.9%	Shares	Sole	2025-11-17
2025-06-30	$3,896	770	0.0%	Shares	Sole	2025-08-14
2025-03-31	$4,073	770	+23.2%	Shares	Sole	2025-05-15
2024-12-31	$4,225	625	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.